Selective group II glutamate metabotropic receptor agonist LY354740 attenuates pentetrazole- and picrotoxin-induced seizures

Polish Journal of Pharmacology

Volumn 51, Issue 6, 1999, Pages 543-545

  Kłodzińska, Aleksandra ^a   Chojnacka Wójcik, Ewa ^a   Pilc, Andrzej ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

LY354740; Metabotropic glutamate receptors; mGluR2 3 agonist; Mice; Pentetrazole; Picrotoxin; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; EGLUMETAD; METABOTROPIC RECEPTOR; PENTETRAZOLE; PICROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DOSE RESPONSE; EPILEPTOGENESIS; MALE; MOUSE; NONHUMAN; SEIZURE;

ANIMALS; BICYCLO COMPOUNDS; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; MALE; MICE; PENTYLENETETRAZOLE; PICROTOXIN; RECEPTORS, METABOTROPIC GLUTAMATE; SEIZURES;

EID: 0342545860     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Attwell P. J. E., Koumentaki A., Abdulghani A. S., Croucher M. J., Bradford H. F.: Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats. Brain Res., 1998, 787, 286-291.
2. Attwell P. J., Kent N. S., Jane D. E., Croucher M. J., Bradford H. R: Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2′R,3′R)-2-(2′,3′-dicarboxycyclopropyl) glycine (DCG-IV). Brain Res., 1998, 805, 138-143.
3. Bradford H. F.: Glutamate, GABA and epilepsy. Prog. Neurobiol., 1995, 47, 477-511.
4. Danysz W., Parsons C. G., Bresnik I., Quack G.: Glutamate in CNS Disorders. Drugs News Perspect., 1996, 8, 261-277.
5. Herron C. E., Williamson R., Collingridge G. L.: A selective N-methyl-D-aspartate antagonist depresses epileptiform activity in rat hippocampal slices. Neurosci. Lett., 1985, 61, 255-260.
6. Kłodzińska A., Chojnacka-Wójcik E., Pałucha A., Brański P., Popik P., Pilc A:. Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models. Neuropharmacology, 1999, 38, 1831-1839.
7. Martin G., Nie Z. G., Siggins G. R.: Metabotropic glutamate receptors regulate N-methyl-D-aspartate-mediated synaptic transmission in nucleus accumbens. J. Neurophysiol., 1997, 78, 3028-3038.
8. Monaghan D. T., Bridges R. J., Cotman C. W.: The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol., 1989, 29, 365-402.
9. Monn J. A., Valli M. J., Massey S. M., Wright R. A., Salhoff C. R., Johnson B. G., Howe T., Alt C. A., Rhodes G. A., Robey R. L., Griffey K. R., Tizzano J. P., Kallman M. J., Helton D. R., Schoepp D. D.: Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. J. Med. Chem., 1997, 40, 528-537.
10. Petralia R. S., Wang Y. X., Niedzielski A. S., Wenthold R. J.: The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience, 1996, 71, 949-976.
11. Pin J. P., Duvoisin R.: The metabotropic glutamate receptors: structure and functions. Neuropharmacology, 1995, 34, 1-26.
12. Shigemoto R., Kinoshita A., Wada E., Nomura S., Ohishi H., Takada M., Flor P. J., Neki A., Abe T., Nakanishi S., Mizuno N.: Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J. Neurosci., 1997, 17, 7503-7522.
13. Urbańska E., Czuczwar S. J., Kleinrok Z., Turski W. A.: Excitatory amino acids in epilepsy. Restor. Neurol. Neurosci., 1998, 13, 25-39.